Method and composition for transdermal drug delivery
US8993520B2 · kind B2 · utility
0Cited by
37References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 25, 2010 |
| Grant date | Mar 31, 2015 |
| Priority date | — |
| Expiry date | Jun 25, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61Q17/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.